A phase III, placebo controlled study investigating liposomal recombinant human Cu/Zn-superoxide dismutase (Lipoxysan) in patients with Peyronie′s disease
Latest Information Update: 19 Feb 2016
At a glance
- Drugs Superoxide dismutase (Primary)
- Indications Peyronie's disease
- Focus Therapeutic Use
Most Recent Events
- 19 Feb 2016 New trial record